Richmond University Medical Center is taking precautions to guard against Coronavirus. VISITOR POLICYCOVID-19 VACCINATIONS


Monoclonal Antibody Treatment

Home » About » COVID-19 Support » Monoclonal Antibody Treatment

Only Emergency Department Directly providing Monoclonal Antibody Treatment for COVID-19

Monoclonal antibodies are a safe and medically-proven effective treatment specifically targeted to COVID-19. RUMC is the only emergency department on Staten Island directly providing this treatment.  It is administered intravenously and travels through the body attaching to the COVID-19 cells. By attaching to the virus cells, it stops COVID-19 from spreading within the body, causing more severe symptoms and greater health risks, including death. The treatment is intended to be given in the early stages to prevent the virus from becoming more severe.

RUMC has treated over 300 patients with monoclonal antibodies so far and in all but one case, these patients did not require admission to the hospital. Many of them in fact reported feeling improvement after receiving the treatment.

People eligible for monoclonal antibody treatment are those who have tested positive for COVID-19 with symptoms starting within the past 10 days. They must also meet any of the following criteria:

  • Be older than 65 years of age
  • Be older than 55 years old with cardiovascular disease, hypertension, or COPD
  • Have diabetes, chronic kidney disease, and/or an immunosuppressive disease
  • Are currently receiving immunosuppressive treatment
  • Have a Body Mass Index (BMI) greater than 35

Anyone who may qualify for monoclonal antibody treatment can come to RUMC’s emergency department at 355 Bard Avenue for evaluation. If they are unsure if they have COVID-19, we will perform a rapid test and PCR test to confirm.

If you or someone you know have questions about monoclonal antibody treatment, please contact your primary care physician, or call RUMC at 844-934-CARE.